Research Focus

Researchers at the Gynecologic Oncology Research Group at Perlmutter Cancer Center are investigating:

PARP inhibitors in ovarian cancer and refractive ovarian cancer.

Different scheduling of standard chemotherapy to improve its efficacy.

The role of mTOR inhibitors in gynecologic cancer.

Our investigations include:

Epidemiology and Prevention

Screening women who are at high risk for developing ovarian, fallopian tube, and primary peritoneal cancer and breast cancer, an investigation that is being conducted by the Lynne Cohen Foundation project.

Contributing to trials of risk-reducing surgery for women at high risk of developing ovarian, Fallopian tube, and primary peritoneal cancer, a study being run by GOG.